Brief comments on three existing approaches for managing neonates at risk of early-onset sepsis.

Early-onset sepsis Group B streptococcus Intrapartum antibiotic prophylaxis Neonatal Sepsis calculator Newborn Prevention Serial clinical observation

Journal

Italian journal of pediatrics
ISSN: 1824-7288
Titre abrégé: Ital J Pediatr
Pays: England
ID NLM: 101510759

Informations de publication

Date de publication:
18 Jul 2021
Historique:
received: 25 01 2021
accepted: 15 06 2021
entrez: 19 7 2021
pubmed: 20 7 2021
medline: 15 12 2021
Statut: epublish

Résumé

Growing concerns regarding the adverse effects of antibiotics during the first days of life and the marked reduction in the incidence of early-onset sepsis (EOS) are changing the clinical practice for managing neonates at risk of EOS. Strategies avoiding unnecessary antibiotics while promoting mother-infant bonding and breastfeeding deserve to be considered. We compare strategies for managing newborns at risk of EOS recommended by the American Academy of Pediatrics, which are among the most followed recommendations worldwide. Currently three different approaches are suggested in asymptomatic full-term or late preterm neonates: i) the conventional management, based on standard perinatal risk factors for EOS alone, ii) the neonatal sepsis calculator, a multivariate risk assessment based on individualized, quantitative risk estimates (relying on maternal risk factors for EOS) combined with physical examination findings at birth and in the following hours and iii) an approach entirely based on newborn clinical condition (serial clinical observation) during the first 48 h of life. We discuss advantages and limitations of these approaches, by analyzing studies supporting each strategy. Approximately 40% of infants who develop EOS cannot be identified on the basis of maternal RFs or laboratory tests, therefore close monitoring of the asymptomatic but at-risk infant remains crucial. A key question is to know what proportion of babies with mild, unspecific symptoms at birth can be managed safely without giving antibiotics. Both neonatal sepsis calculator and serial clinical observation may miss cases of EOS, and clinical vigilance for all neonates is essential There is a need to assess which symptoms at birth are more predictive of EOS, and therefore require immediate interventions, or symptoms that can be carefully reevaluated without necessarily treat immediately the neonate with antibiotics. Studies comparing strategies for managing neonates are recommended.

Sections du résumé

BACKGROUND BACKGROUND
Growing concerns regarding the adverse effects of antibiotics during the first days of life and the marked reduction in the incidence of early-onset sepsis (EOS) are changing the clinical practice for managing neonates at risk of EOS. Strategies avoiding unnecessary antibiotics while promoting mother-infant bonding and breastfeeding deserve to be considered.
MAIN BODY METHODS
We compare strategies for managing newborns at risk of EOS recommended by the American Academy of Pediatrics, which are among the most followed recommendations worldwide. Currently three different approaches are suggested in asymptomatic full-term or late preterm neonates: i) the conventional management, based on standard perinatal risk factors for EOS alone, ii) the neonatal sepsis calculator, a multivariate risk assessment based on individualized, quantitative risk estimates (relying on maternal risk factors for EOS) combined with physical examination findings at birth and in the following hours and iii) an approach entirely based on newborn clinical condition (serial clinical observation) during the first 48 h of life. We discuss advantages and limitations of these approaches, by analyzing studies supporting each strategy. Approximately 40% of infants who develop EOS cannot be identified on the basis of maternal RFs or laboratory tests, therefore close monitoring of the asymptomatic but at-risk infant remains crucial. A key question is to know what proportion of babies with mild, unspecific symptoms at birth can be managed safely without giving antibiotics.
CONCLUSIONS CONCLUSIONS
Both neonatal sepsis calculator and serial clinical observation may miss cases of EOS, and clinical vigilance for all neonates is essential There is a need to assess which symptoms at birth are more predictive of EOS, and therefore require immediate interventions, or symptoms that can be carefully reevaluated without necessarily treat immediately the neonate with antibiotics. Studies comparing strategies for managing neonates are recommended.

Identifiants

pubmed: 34275466
doi: 10.1186/s13052-021-01107-3
pii: 10.1186/s13052-021-01107-3
pmc: PMC8286612
doi:

Substances chimiques

Anti-Bacterial Agents 0

Types de publication

Letter

Langues

eng

Sous-ensembles de citation

IM

Pagination

159

Informations de copyright

© 2021. The Author(s).

Références

J Matern Fetal Neonatal Med. 2020 Mar;33(6):1036-1043
pubmed: 30058404
Pediatrics. 2018 Apr;141(4):
pubmed: 29599112
Curr Opin Pediatr. 2020 Apr;32(2):245-251
pubmed: 31851052
Jt Comm J Qual Patient Saf. 2016 May;42(5):232-9
pubmed: 27066927
JAMA Pediatr. 2017 Apr 1;171(4):365-371
pubmed: 28241253
Lancet Infect Dis. 2021 May;21(5):e134-e140
pubmed: 33129425
J Pediatr. 2015 Apr;166(4):1070-4
pubmed: 25641240
Eur J Pediatr. 2020 Dec;179(12):1859-1865
pubmed: 32623627
J Pediatr. 2019 Oct;213:10-12
pubmed: 31256915
Pediatrics. 2011 Nov;128(5):e1155-63
pubmed: 22025590
J Perinatol. 2013 Mar;33(3):198-205
pubmed: 22814941
Curr Opin Pediatr. 2013 Apr;25(2):161-6
pubmed: 23407183
Pediatrics. 2018 Dec;142(6):
pubmed: 30455342
PLoS One. 2019 Mar 20;14(3):e0212784
pubmed: 30893310
JAMA Pediatr. 2019 Nov 1;173(11):1032-1040
pubmed: 31479103
Pediatrics. 2014 Jan;133(1):30-6
pubmed: 24366992
J Matern Fetal Neonatal Med. 2015 Jul;28(10):1123-7
pubmed: 25034325

Auteurs

E Vaccina (E)

Post Graduate School of Paediatrics, Department of Medical and Surgical Sciences of the Mothers, Children and Adults, University of Modena and Reggio Emilia, via del Pozzo 71, 41124, Modena, Italy.

A Luglio (A)

Post Graduate School of Paediatrics, Department of Medical and Surgical Sciences of the Mothers, Children and Adults, University of Modena and Reggio Emilia, via del Pozzo 71, 41124, Modena, Italy.

M Ceccoli (M)

Post Graduate School of Paediatrics, Department of Medical and Surgical Sciences of the Mothers, Children and Adults, University of Modena and Reggio Emilia, via del Pozzo 71, 41124, Modena, Italy.

M Lecis (M)

Post Graduate School of Paediatrics, Department of Medical and Surgical Sciences of the Mothers, Children and Adults, University of Modena and Reggio Emilia, via del Pozzo 71, 41124, Modena, Italy.

F Leone (F)

Post Graduate School of Paediatrics, Department of Medical and Surgical Sciences of the Mothers, Children and Adults, University of Modena and Reggio Emilia, via del Pozzo 71, 41124, Modena, Italy.

T Zini (T)

Post Graduate School of Paediatrics, Department of Medical and Surgical Sciences of the Mothers, Children and Adults, University of Modena and Reggio Emilia, via del Pozzo 71, 41124, Modena, Italy.

G Toni (G)

Post Graduate School of Paediatrics, Department of Medical and Surgical Sciences of the Mothers, Children and Adults, University of Modena and Reggio Emilia, via del Pozzo 71, 41124, Modena, Italy.

L Lugli (L)

Neonatal Intensive Care Unit, Department of Medical and Surgical Sciences of the Mothers, Children and Adults, University of Modena and Reggio Emilia, via del Pozzo 71, 41124, Modena, Italy.

L Lucaccioni (L)

Pediatric Unit, Department of Medical and Surgical Sciences of the Mothers, Children and Adults, University of Modena and Reggio Emilia, via del Pozzo 71, 41124, Modena, Italy.

L Iughetti (L)

Pediatric Unit, Department of Medical and Surgical Sciences of the Mothers, Children and Adults, University of Modena and Reggio Emilia, via del Pozzo 71, 41124, Modena, Italy.

A Berardi (A)

Neonatal Intensive Care Unit, Department of Medical and Surgical Sciences of the Mothers, Children and Adults, University of Modena and Reggio Emilia, via del Pozzo 71, 41124, Modena, Italy. alberto.berardi@unimore.it.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH